ImageneBio, Inc. Operating Lease, Liability, Noncurrent
ImageneBio, Inc. (IMA) had Operating Lease, Liability, Noncurrent of $0 as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-30: Operating Lease, Liability, Noncurrent $0.00.
- 2026-03-31: Operating Lease, Liability, Noncurrent $110.00K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $713.00K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $1.28M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $110.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $713.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $1.28M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.84M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $2.72M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $239.00K 10-K · filed 2026-03-10 | $3.74M 10-K · filed 2025-03-06 |
| 2024-09-30 | $4.47M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $5.40M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $6.30M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $7.18M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $8.02M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.06M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $3.43M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.79M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $4.14M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $4.48M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.82M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $5.13M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $5.45M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.76M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.05M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |